- Home
- IIM vs CRMD Comparison
IIM vs CRMD Comparison
Compare IIM & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIM
- CRMD
- Stock Information
- Founded
- IIM 1993
- CRMD 2006
- Country
- IIM United States
- CRMD United States
- Employees
- IIM N/A
- CRMD N/A
- Industry
- IIM Investment Managers
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- IIM Finance
- CRMD Health Care
- Exchange
- IIM Nasdaq
- CRMD Nasdaq
- Market Cap
- IIM 584.6M
- CRMD 645.0M
- IPO Year
- IIM N/A
- CRMD 2010
- Fundamental
- Price
- IIM $11.56
- CRMD $7.67
- Analyst Decision
- IIM
- CRMD Strong Buy
- Analyst Count
- IIM 0
- CRMD 6
- Target Price
- IIM N/A
- CRMD $14.50
- AVG Volume (30 Days)
- IIM 122.2K
- CRMD 2.6M
- Earning Date
- IIM 01-01-0001
- CRMD 05-08-2025
- Dividend Yield
- IIM 4.63%
- CRMD N/A
- EPS Growth
- IIM N/A
- CRMD N/A
- EPS
- IIM 0.02
- CRMD N/A
- Revenue
- IIM N/A
- CRMD $43,472,170.00
- Revenue This Year
- IIM N/A
- CRMD $207.65
- Revenue Next Year
- IIM N/A
- CRMD $50.13
- P/E Ratio
- IIM $591.50
- CRMD N/A
- Revenue Growth
- IIM N/A
- CRMD N/A
- 52 Week Low
- IIM $9.94
- CRMD $3.61
- 52 Week High
- IIM $12.32
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- IIM 40.88
- CRMD 47.85
- Support Level
- IIM $11.25
- CRMD $6.32
- Resistance Level
- IIM $11.71
- CRMD $7.71
- Average True Range (ATR)
- IIM 0.22
- CRMD 0.47
- MACD
- IIM -0.01
- CRMD 0.23
- Stochastic Oscillator
- IIM 50.42
- CRMD 92.41
About IIM Invesco Value Municipal Income Trust
Invesco Value Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide common shareholders with current income which is exempt from federal income tax.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.